Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 2/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.46 |
| ▸ | NPY4R | P50391 | 2/20 | 0.46 |
| ▸ | NPY1R | P25929 | 1/20 | 0.46 |
| ▸ | NPY2R | P49146 | 1/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.42 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.42 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.42 |
| ▸ | FURIN | P09958 | 2/20 | 0.42 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 2/20 | 0.40 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31027958 | 0.93 | NPY1R (0.46) | NTSR2NTSR1NPY4RNPY1RNPY2R | |
| SCHEMBL27165073 | 0.93 | CPB2 (0.45) | FURINCPB2GSR | |
| SCHEMBL27164802 | 0.93 | CPB2 (0.45) | FURINCPB2GSR | |
| SCHEMBL30974486 | 0.92 | ERAP2 (0.43) | NTSR2NTSR1NPY4RNPY1RNPY2R | |
| SCHEMBL29591847 | 0.92 | ERAP2 (0.48) | NTSR2NTSR1NPY4RNPY1RNPY2R | |
| SCHEMBL10336059 | 0.92 | BACE1 (0.51) | BACE1BACE2 | |
| SCHEMBL10336062 | 0.92 | BACE1 (0.51) | BACE1BACE2 | |
| SCHEMBL10381550 | 0.92 | FURIN (0.48) | NTSR2NTSR1NPY4RNPY1RNPY2R | |
| SCHEMBL10381547 | 0.92 | FURIN (0.48) | NTSR2NTSR1NPY4RNPY1RNPY2R | |
| SCHEMBL29682467 | 0.92 | NPY4R (0.52) | NTSR2NTSR1NPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |